Vocabria tablets 30mg contain Cabotegravir Sodium, an integrase inhibitor manufactured by ViiV Healthcare. It is used in combination with rilpivirine for the short-term treatment of HIV-1 infection in adults, and can serve as an oral lead-in to long-acting injectable treatments. (YJ code: 6250050F1024, standard: 30mg 1 tablet)
Vocabria tablets 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
